Upgrade to SI Premium - Free Trial

NCCN updates myeloma guidelines, names clonoSEQ for MRD testing

September 17, 2026 8:00 AM
Adaptive Biotechnologies (Nasdaq: ADPT) announced that the National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines in Oncology ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA